Will Suhikian
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
About Will Suhikian
Will Suhikian is recorded as Analyst at Leerink Partners. Will Suhikian has spoken on 2 earnings calls across 2 companies, most recently for Travere Therapeutics, Inc. on May 4, 2026. Those appearances were for Travere Therapeutics, Inc. (TVTX) and Ultragenyx Pharmaceutical Inc. (RARE). The companies whose calls Will Suhikian spoke on are classified in the Healthcare sector.
Will Suhikian on recent calls
“The one for us on FSGS, you guys have messaged several times that the launch is expected to progress at a faster rate than IJ nephropathy. Could you please characterize what you are seeing at this early stage and how it compares to the original IGAN rollout a few years ago?”
“I have one on Angelman and then a quick follow-up. So, for GTX102, the company has consistently stated that it is the most potent ASO in development. We're just wondering, is this claim based on the ATS knockdown or perhaps its mRNA or protein increases preclinically?”
Affiliation history
-
Leerink Partners
Analyst
Transcript header (unverified)
Current